Status and phase
Conditions
Treatments
About
The purpose of this study is to evaluate pharmacokinetics of CKD-501 in patients with impaired hepatic function compared with normal hepatic function.
Full description
A Phase 1, Non-randomized, Open, Parallel-Group study.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
A. Inclusion Criteria
[The subjects with impaired hepatic function]
[The subjects with normal hepatic function]
B. exclusion criteria
[The subjects with impaired hepatic function]
[The subjects with normal hepatic function]
26 participants in 4 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal